German firm Carl Zeiss sees growing demand for eye care tech in India
The Hindu
German tech firm Carl Zeiss boosts AI-driven medical device market in India with rising DR cases & increasing diabetic population.
Carl Zeiss, a German technology firm that manufactures optical systems and optoelectronics, said India has been a booming market for its artificial intelligence (AI) driven medical devices as the country witnessed a spike in diabetic retinopathy (DR) cases in recent years.
AI in medicine was a boon in the management of diseases like DR as the technology assists in screening patients and enables early detection of symptoms, enabling timely treatment, said Dipu Bose, Head, Carl Zeiss Meditec, India & Neighbouring Markets.
Latest data from the Indian Council of Medical Research published in 2023, shows the prevalence of diabetes in India reached an alarming 10.1 crore. According to the International Diabetes Federation (IDF), in 2021, there were an estimated 77 million adults living with diabetes in the country, accounting for 1 in 7 adults worldwide who are living with diabetes. Also, DR contributed significantly to cases of blindness in the country, reported the National Programme for Control of Blindness and Visual Impairment.
“The integration of AI and diagnostic imaging promises effective management of DR,’‘ Mr. Bose said. He also claimed that “demand for Zeiss products in India has been steadily rising. As the country’s healthcare landscape modernises, innovative imaging equipment is gaining importance and our offerings including ophthalmic diagnostic tools are finding fast acceptance among leading eye-care providers in the country.”
Zeiss’ medical devices are also used for rear of an eye photography, helps in diagnosing conditions like cataracts, age-related macular degeneration, and other eye diseases.
“Our R&D centres in India employ 500 engineers and technicians. They actively contribute to the design and development of products and tools for the local and global markets,’‘ Mr. Bose added.
The ZEISS Group generated an annual revenue of more than 10 billion euros in the October-September fiscal last year with India contributing ₹1800 crore to it.
Rupee trading in narrow range as U.S. dollar strengthens, Brent oil rises amid Ukraine-Russia conflict, FIIs sell equities.
Billionaire Gautam Adani indicted in U.S. for fraud and bribery, facing charges of defrauding American investors.
Air India has signed an agreement with Bengaluru Airport City Limited (BACL), a subsidiary of Bangalore International Airport Limited (BIAL), to develop a built-to-suit facility for the AME program that will feature modern classrooms, well-equipped laboratories for practical training and a team of qualified trainers.
Zepto raises $350 million in largest domestic fundraise in India, backed by leading financial institutions and notable individuals.
Adani Enterprises Ltd stock dips on NSE and BSE after Kenyan project cancellations and U.S. court allegations.
HSBC Flash India PMI shows uptick in private sector activity, with rising cost pressures and increased prices for customers.
Rupee rises slightly against US dollar amid geopolitical pressures, foreign outflows, and domestic equities; Brent oil surges.
Sensex and Nifty rebound in early trade driven by value buying, bank stock rally, and positive global cues.
The pandemic-induced downturn marked a turning point for cab drivers in Bengaluru. According to Tanveer Pasha, president, Ola and Uber Drivers’ Association, the number of active cabs in the city has dropped from over 1 lakh before the pandemic to just around 30,000 today.
Amazon will likely face an EU investigation next year into whether it favours its own brand products, said sources.
White House addresses bribery charges against Indian billionaire Adani, expresses confidence in U.S.-India relationship.